192 related articles for article (PubMed ID: 29017921)
21. Taba: A Tool to Analyze the Binding Affinity.
da Silva AD; Bitencourt-Ferreira G; de Azevedo WF
J Comput Chem; 2020 Jan; 41(1):69-73. PubMed ID: 31410856
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of using molecular docking-based virtual screening for searching dual target kinase inhibitors.
Zhou S; Li Y; Hou T
J Chem Inf Model; 2013 Apr; 53(4):982-96. PubMed ID: 23506306
[TBL] [Abstract][Full Text] [Related]
23. Assessing an ensemble docking-based virtual screening strategy for kinase targets by considering protein flexibility.
Tian S; Sun H; Pan P; Li D; Zhen X; Li Y; Hou T
J Chem Inf Model; 2014 Oct; 54(10):2664-79. PubMed ID: 25233367
[TBL] [Abstract][Full Text] [Related]
24. Cross-docking of inhibitors into CDK2 structures. 1.
Duca JS; Madison VS; Voigt JH
J Chem Inf Model; 2008 Mar; 48(3):659-68. PubMed ID: 18324799
[TBL] [Abstract][Full Text] [Related]
25. Molecular modeling studies to characterize N-phenylpyrimidin-2-amine selectivity for CDK2 and CDK4 through 3D-QSAR and molecular dynamics simulations.
Chohan TA; Chen JJ; Qian HY; Pan YL; Chen JZ
Mol Biosyst; 2016 Apr; 12(4):1250-68. PubMed ID: 26883408
[TBL] [Abstract][Full Text] [Related]
26. Molegro Virtual Docker for Docking.
Bitencourt-Ferreira G; de Azevedo WF
Methods Mol Biol; 2019; 2053():149-167. PubMed ID: 31452104
[TBL] [Abstract][Full Text] [Related]
27. Molecular dynamics and QM/MM-based 3D interaction analyses of cyclin-E inhibitors.
Pasha FA; Neaz MM
J Mol Model; 2013 Feb; 19(2):879-91. PubMed ID: 23086460
[TBL] [Abstract][Full Text] [Related]
28. DrugScoreRNA--knowledge-based scoring function to predict RNA-ligand interactions.
Pfeffer P; Gohlke H
J Chem Inf Model; 2007; 47(5):1868-76. PubMed ID: 17705464
[TBL] [Abstract][Full Text] [Related]
29. Docking with AutoDock4.
Bitencourt-Ferreira G; Pintro VO; de Azevedo WF
Methods Mol Biol; 2019; 2053():125-148. PubMed ID: 31452103
[TBL] [Abstract][Full Text] [Related]
30. Imidazo[1,2-c]pyrimidin-5(6H)-one as a novel core of cyclin-dependent kinase 2 inhibitors: Synthesis, activity measurement, docking, and quantum mechanical scoring.
Ajani H; Jansa J; Köprülüoğlu C; Hobza P; Kryštof V; Lyčka A; Lepsik M
J Mol Recognit; 2018 Sep; 31(9):e2720. PubMed ID: 29687635
[TBL] [Abstract][Full Text] [Related]
31. Binding free energy estimation for protein-ligand complex based on MM-PBSA with various partial charge models.
Fu T; Jin Z; Xiu Z; Li G
Curr Pharm Des; 2013; 19(12):2293-307. PubMed ID: 23082979
[TBL] [Abstract][Full Text] [Related]
32. Prediction of multiple binding modes of the CDK2 inhibitors, anilinopyrazoles, using the automated docking programs GOLD, FlexX, and LigandFit: an evaluation of performance.
Sato H; Shewchuk LM; Tang J
J Chem Inf Model; 2006; 46(6):2552-62. PubMed ID: 17125195
[TBL] [Abstract][Full Text] [Related]
33. The Impact of Crystallographic Data for the Development of Machine Learning Models to Predict Protein-Ligand Binding Affinity.
Veit-Acosta M; de Azevedo Junior WF
Curr Med Chem; 2021 Oct; 28(34):7006-7022. PubMed ID: 33568025
[TBL] [Abstract][Full Text] [Related]
34. A structure-guided approach for protein pocket modeling and affinity prediction.
Varela R; Cleves AE; Spitzer R; Jain AN
J Comput Aided Mol Des; 2013 Nov; 27(11):917-34. PubMed ID: 24214361
[TBL] [Abstract][Full Text] [Related]
35. Ensemble learning from ensemble docking: revisiting the optimum ensemble size problem.
Mohammadi S; Narimani Z; Ashouri M; Firouzi R; Karimi-Jafari MH
Sci Rep; 2022 Jan; 12(1):410. PubMed ID: 35013496
[TBL] [Abstract][Full Text] [Related]
36. A 3D-QSAR Analysis of CDK2 Inhibitors Using FMO Calculations and PLS Regression.
Yoshida T; Hirono S
Chem Pharm Bull (Tokyo); 2019; 67(6):546-555. PubMed ID: 31155560
[TBL] [Abstract][Full Text] [Related]
37. Molecular simulation studies on the binding selectivity of 2-anilino-4-(thiazol-5-yl)-pyrimidines in complexes with CDK2 and CDK7.
Chohan TA; Qian HY; Pan YL; Chen JZ
Mol Biosyst; 2016 Jan; 12(1):145-61. PubMed ID: 26565382
[TBL] [Abstract][Full Text] [Related]
38. Comparing sixteen scoring functions for predicting biological activities of ligands for protein targets.
Xu W; Lucke AJ; Fairlie DP
J Mol Graph Model; 2015 Apr; 57():76-88. PubMed ID: 25682361
[TBL] [Abstract][Full Text] [Related]
39. New scoring functions for virtual screening from molecular dynamics simulations with a quantum-refined force-field (QRFF-MD). Application to cyclin-dependent kinase 2.
Ferrara P; Curioni A; Vangrevelinghe E; Meyer T; Mordasini T; Andreoni W; Acklin P; Jacoby E
J Chem Inf Model; 2006; 46(1):254-63. PubMed ID: 16426061
[TBL] [Abstract][Full Text] [Related]
40. Combined Ensemble Docking and Machine Learning in Identification of Therapeutic Agents with Potential Inhibitory Effect on Human CES1.
Briand E; Thomsen R; Linnet K; Rasmussen HB; Brunak S; Taboureau O
Molecules; 2019 Jul; 24(15):. PubMed ID: 31362390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
